Twitter Logo Youtube Circle Icon LinkedIn Icon

The Legal 500 Hall of Fame Icon The Legal 500 Hall of Fame highlights individuals who have received constant praise by their clients for continued excellence. The Hall of Fame highlights, to clients, the law firm partners who are at the pinnacle of the profession. In the United Kingdon, the criteria for entry is to have been recognised by The Legal 500 as one of the elite leading lawyers for eight years. These partners are highlighted below and throughout the editorial.
Click here for more details

United Kingdom > East Anglia > TMT (technology, media and telecoms) > Biotechnology > Law firm and leading lawyer rankings



Who Represents Who

Find out which law firms are representing which Biotechnology clients in East Anglia using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Taylor Wessing LLP's 'life science and drug discovery domain expertise is second-to-none in the UK; it has deep industry knowledge and response times are rapid'. The firm's domain expertise and focus on large venture capital transactions see it heavily involved in the biotechnology industry for clients based both in the innovation hub of Cambridge and overseas. Malcolm Bates and regulatory expert Tim Worden lead the transactional team and focus on complex global licensing, collaboration deals and contract disputes, as well as advising on IP and IT aspects of venture capital financings, joint ventures, M&A and IPOs. David Mardle, who is co-head of the firm's international corporate practice, also has extensive experience in equity funding transactions in the technology and life sciences sectors. The firm's client base includes leading names in the biotechnology sector such as French company TxCell and UK-based cell therapy company Oxford BioMedica. Bates recently advised pioneering RNA activation therapeutics company MiNA Therapeutics on a collaboration and licensing agreement with Boehringer Ingelheim for the development of new compounds to treat fibrotic liver diseases. He also handled commercial and IP agreements for Cambridge-based biotech Mission Therapeutics.

Mills & Reeve LLP¬†provides ‚Äėan excellent level of service and response times are very fast‚Äė. One client remarks that the practice provides ‚Äėfirst-class, pragmatic and timely advice'. The firm handles¬†corporate and commercial transactions, patents and IP, privacy, regulation and compliance, HR, product liability, litigation, tax and real estate matters for biotechnology companies. It is highly regarded for research collaborations and licensing agreements across a range of therapeutic areas. New arrival James Fry, who joined from¬†Eversheds Sutherland (International) LLP¬†in late 2017, leads the multi-disciplinary life sciences practice and is praised for his ‚Äėexcellent sector knowledge'. He acted for speciality pharmaceuticals business Diurnal Group in setting up¬†its supply chain for the production of two drug candidates.¬†Finance specialist Zickie Lim, who handled a syndicated financing for¬†PredictImmune Limited, and capital markets expert Stephen Hamilton¬†are also recommended.¬†IP partner¬†Alasdair Poore, corporate partner¬†Anthony McGurk, disputes specialist¬†Graeme Menzies¬†and head of technology¬†Kevin Calder¬†also play central roles in the firm's work for biotechnology clients.

Marks & Clerk LLP is a niche intellectual property firm that has a significant client base in the biotechnology sector. The clients account for a substantial proportion of the workload of managing associate and corporate team head Simon Portman and solicitor Rayyan Mughal, who recently joined the firm from VSH Law. Portman's recent highlights include advising ReagentBio Limited on branding and trade mark filing for the provision of assays for academic, pharmaceutical and veterinary research. He also helped New England Biolabs (UK) interpret and implement regulatory standards for the storage, provision and supply of patented genetically modified organisms, which included advice on internal procedures and labelling requirements.

At Penningtons Manches Cooper, biotechnology is a key industry sector across the firm's national network of offices and the key lawyers in Cambridge frequently advise start-ups and established companies in the sector on corporate and finance matters. Corporate partner Ross McNaughton plays a key part in the firm's life sciences team and last year he assisted a drug discovery company with drafting and negotiating a master services agreement for the provision of data room services by a US company, which involved complex issues around data protection. Senior associate Rachel Bradley in the IP, IT and commercial practice has more than 12 years' experience, which includes a stint as corporate counsel for a pharmaceutical company.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

GC Diversity and Inclusion Report

In partnership with...

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in East Anglia for Biotechnology

Legal Developments in the UK

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases in the UK

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to